Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124157213 | 12415721 | 3 | F | 20160629 | 20160530 | 20160706 | PER | PHEH2016US012699 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160707 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124157213 | 12415721 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG (PATCH 5 CM2, 09 MG DAILY RIVASTIGMINE BASE) | U | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | ||||||
| 124157213 | 12415721 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG (PATCH 10 CM2, 18 MG DAILY RIVASTIGMINE BASE) | U | 4345C | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||
| 124157213 | 12415721 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 124157213 | 12415721 | 4 | C | CITROCALCIO | 2 | Unknown | UNK | U | 0 | ||||||||||
| 124157213 | 12415721 | 5 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124157213 | 12415721 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124157213 | 12415721 | 7 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124157213 | 12415721 | 8 | C | VIT E//TOCOPHEROL | 2 | Unknown | UNK | U | 0 | ||||||||||
| 124157213 | 12415721 | 9 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124157213 | 12415721 | 10 | C | DICLOFENAC | DICLOFENAC | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124157213 | 12415721 | 1 | Product used for unknown indication |
| 124157213 | 12415721 | 3 | Product used for unknown indication |
| 124157213 | 12415721 | 4 | Product used for unknown indication |
| 124157213 | 12415721 | 5 | Product used for unknown indication |
| 124157213 | 12415721 | 6 | Product used for unknown indication |
| 124157213 | 12415721 | 7 | Product used for unknown indication |
| 124157213 | 12415721 | 8 | Product used for unknown indication |
| 124157213 | 12415721 | 9 | Product used for unknown indication |
| 124157213 | 12415721 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124157213 | 12415721 | Product adhesion issue | |
| 124157213 | 12415721 | Pruritus | |
| 124157213 | 12415721 | Skin irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |